{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:33:14Z","timestamp":1769830394523,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Prescription drug monitoring programs (PDMPs) have been widely adopted as a tool to address the prescription opioid epidemic in the United States. PDMP integration and mandatory use policies are 2 approaches states have implemented to increase use of PDMPs by prescribers. While the effectiveness of these approaches is mixed, it is unclear what factors motivated states to implement them. This study examines whether opioid dispensing, adverse health outcomes, or other non\u2013health-related factors motivated implementation of these PDMP approaches.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Time-to-event analysis was performed using lagged state-year covariates to reflect values from the year prior. Extended Cox regression estimated the association of states\u2019 rates of opioid dispensing, prescription opioid overdose deaths, and neonatal opioid withdrawal syndrome with implementation of PDMP integration and mandatory use policies from 2009 to 2020, controlling for demographic and economic factors, state government and political factors, and prior opioid policies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In our main model, prior opioid dispensing (HR 2.31, 95% CI 1.17, 4.57), neonatal opioid withdrawal syndrome hospitalizations (HR 1.55, 95% CI 1.09, 2.19), and number of prior opioid policies (HR 2.13, 95% CI 1.13, 4.00) were associated with mandatory use policies. Prior prescription opioid overdose deaths (HR 1.21, 95% CI 1.08, 1.35) were also associated with mandatory use policies in a model that did not include opioid dispensing or neonatal opioid withdrawal syndrome. No study variables were associated with implementation of PDMP integration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Understanding state-level factors associated with implementing PDMP approaches can provide insights into factors that motivate the adoption of future public health interventions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamia\/ocae160","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:20:49Z","timestamp":1718986849000},"page":"2337-2346","source":"Crossref","is-referenced-by-count":2,"title":["State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009\u20132020"],"prefix":"10.1093","volume":"31","author":[{"given":"Christian E","family":"Johnson","sequence":"first","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA 52242, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Chrischilles","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA 52242, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Arndt","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Carver College of Medicine, University of Iowa , Iowa City, IA 52242, United States"},{"name":"Department of Biostatistics, College of Public Health, University of Iowa , Iowa City, IA 52242, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M","family":"Carnahan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA 52242, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"2024092007524332700_ocae160-B1","author":"Centers for Disease Control and Prevention"},{"key":"2024092007524332700_ocae160-B2","volume-title":"Drug Overdose Deaths in the United States, 1999\u20132019","author":"Hedegaard","year":"2020"},{"issue":"25","key":"2024092007524332700_ocae160-B3","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMra1600879","article-title":"Neonatal abstinence syndrome","volume":"375","author":"McQueen","year":"2016","journal-title":"N Engl J Med"},{"key":"2024092007524332700_ocae160-B4","author":"Agency for Healthcare Research and Quality"},{"key":"2024092007524332700_ocae160-B5","author":"Centers for Disease Control and Prevention"},{"key":"2024092007524332700_ocae160-B6","author":"Office of the National Coordinator for Health Information Technology","year":"2019"},{"key":"2024092007524332700_ocae160-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2019.02.010","article-title":"Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing","volume":"199","author":"Strickler","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2024092007524332700_ocae160-B8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1377\/hlthaff.2014.1085","article-title":"Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access","volume":"34","author":"Rutkow","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"2024092007524332700_ocae160-B9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/pme.12469","article-title":"How clinicians use prescription drug monitoring programs: a qualitative inquiry","volume":"15","author":"Hildebran","year":"2014","journal-title":"Pain Med"},{"key":"2024092007524332700_ocae160-B10","year":"2020"},{"issue":"10","key":"2024092007524332700_ocae160-B11","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/pm\/pnab051","article-title":"Opioid prescribing after implementation of single click access to a state prescription drug monitoring program database in a health system\u2019s electronic health record","volume":"22","author":"Weiner","year":"2021","journal-title":"Pain Med"},{"issue":"1","key":"2024092007524332700_ocae160-B12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"2024092007524332700_ocae160-B13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review","volume":"168","author":"Fink","year":"2018","journal-title":"Ann Intern Med"},{"issue":"12","key":"2024092007524332700_ocae160-B14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jpain.2019.04.007","article-title":"Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review","volume":"20","author":"Wilson","year":"2019","journal-title":"J Pain"},{"issue":"1","key":"2024092007524332700_ocae160-B15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/epirev\/mxaa002","article-title":"Prescription drug monitoring programs and prescription opioid-related outcomes in the United States","volume":"42","author":"Puac-Polanco","year":"2020","journal-title":"Epidemiol Rev"},{"issue":"2","key":"2024092007524332700_ocae160-B16","doi-asserted-by":"crossref","first-page":"e2036687","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the U.S. opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2024092007524332700_ocae160-B17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1377\/hlthaff.2018.0512","article-title":"Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions","volume":"37","author":"Bao","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"2024092007524332700_ocae160-B18","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"2024092007524332700_ocae160-B19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1377\/hlthaff.2016.1141","article-title":"States with prescription drug monitoring mandates saw a reduction in opioids prescribed to Medicaid enrollees","volume":"36","author":"Wen","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"2024092007524332700_ocae160-B20","doi-asserted-by":"crossref","first-page":"102408","DOI":"10.1016\/j.jhealeco.2020.102408","article-title":"Must-access prescription drug monitoring programs and the opioid overdose epidemic: the unintended consequences","volume":"75","author":"Kim","year":"2021","journal-title":"J Health Econ"},{"issue":"2","key":"2024092007524332700_ocae160-B21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"2024092007524332700_ocae160-B22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the U.S. opioid epidemic","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"issue":"3","key":"2024092007524332700_ocae160-B23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/ADM.0000000000000905","article-title":"The impact of a PDMP-EHR data integration combined with clinical decision support on opioid and benzodiazepine prescribing across clinicians in a metropolitan area","volume":"16","author":"Calcaterra","year":"2022","journal-title":"J Addict Med"},{"issue":"9","key":"2024092007524332700_ocae160-B24","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/hec.4360","article-title":"The complementarity of drug monitoring programs and health IT for reducing opioid-related mortality and morbidity","volume":"30","author":"Wang","year":"2021","journal-title":"Health Econ"},{"key":"2024092007524332700_ocae160-B25","doi-asserted-by":"crossref","first-page":"103497","DOI":"10.1016\/j.regsciurbeco.2019.103497","article-title":"Prescription drug monitoring programs and neonatal outcomes","volume":"81","author":"Gihleb","year":"2020","journal-title":"Region Sci Urban Econ"},{"issue":"1","key":"2024092007524332700_ocae160-B26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jphsr\/rmab069","article-title":"The association between pill mill legislation and neonatal abstinence syndrome","volume":"13","author":"Anwar","year":"2021","journal-title":"J Pharm Health Serv Res"},{"key":"2024092007524332700_ocae160-B27","doi-asserted-by":"crossref","first-page":"108772","DOI":"10.1016\/j.drugalcdep.2021.108772","article-title":"Predictors of U.S. states\u2019 adoption of naloxone access laws, 2001\u20132017","volume":"225","author":"Bohler","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2024092007524332700_ocae160-B28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09687637.2016.1158239","article-title":"Factors driving the diffusion of medical marijuana legalisation in the United States","volume":"24","author":"Bradford","year":"2016","journal-title":"Drugs Educ Prev Policy"},{"issue":"9","key":"2024092007524332700_ocae160-B29","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2105\/AJPH.2015.302670","article-title":"Diffusion of impaired driving laws among U.S. states","volume":"105","author":"Macinko","year":"2015","journal-title":"Am J Public Health"},{"issue":"2","key":"2024092007524332700_ocae160-B30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1475-6773.13548","article-title":"The importance of data source in prescription drug monitoring program research","volume":"56","author":"Horwitz","year":"2021","journal-title":"Health Serv Res"},{"key":"2024092007524332700_ocae160-B31","author":"Kaiser Family Foundation","year":"2021"},{"key":"2024092007524332700_ocae160-B32","author":"U.S. Census Bureau","year":"2022"},{"key":"2024092007524332700_ocae160-B33","author":"RC Fording","year":"2018"},{"key":"2024092007524332700_ocae160-B34","author":"United Health Foundation"},{"key":"2024092007524332700_ocae160-B35","author":"Kaiser Family Foundation","year":"2022"},{"issue":"5","key":"2024092007524332700_ocae160-B36","first-page":"125","article-title":"Implementation of a statewide surveillance system for neonatal abstinence syndrome\u2014Tennessee, 2013","volume":"64","author":"Warren","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2024092007524332700_ocae160-B37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2024092007524332700_ocae160-B38","author":"Nyakeriga","year":"2020"},{"key":"2024092007524332700_ocae160-B39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"U.S. regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations","volume":"46","author":"Unik","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"43","key":"2024092007524332700_ocae160-B40","doi-asserted-by":"crossref","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","article-title":"Racial\/Ethnic and age group differences in opioid and synthetic opioid\u2013involved overdose deaths among adults aged \u226518 years in metropolitan areas\u2014United States, 2015-2017","volume":"68","author":"Lippold","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"2024092007524332700_ocae160-B41","doi-asserted-by":"crossref","first-page":"e181588","DOI":"10.1001\/jamanetworkopen.2018.1588","article-title":"Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion","volume":"1","author":"Saloner","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2024092007524332700_ocae160-B42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2105\/AJPH.2018.304338","article-title":"Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment","volume":"108","author":"Sharp","year":"2018","journal-title":"Am J Public Health"},{"issue":"3","key":"2024092007524332700_ocae160-B43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11904-018-0397-9","article-title":"Syringe decriminalization advocacy in red states: lessons from the North Carolina Harm Reduction Coalition","volume":"15","author":"Cloud","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2024092007524332700_ocae160-B44","doi-asserted-by":"crossref","first-page":"113470","DOI":"10.1016\/j.socscimed.2020.113470","article-title":"Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities","volume":"268","author":"Ezell","year":"2021","journal-title":"Soc Sci Med"},{"key":"2024092007524332700_ocae160-B45","author":"U.S. Department of Justice"},{"key":"2024092007524332700_ocae160-B46","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"2024092007524332700_ocae160-B47","author":"Richwine","year":"2023"},{"issue":"6","key":"2024092007524332700_ocae160-B48","doi-asserted-by":"crossref","first-page":"e209085","DOI":"10.1001\/jamanetworkopen.2020.9085","article-title":"Evaluation of prescription drug monitoring program integration with hospitals electronic health records by U.S. county-level opioid prescribing rates","volume":"3","author":"Holmgren","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024092007524332700_ocae160-B49","author":"Vaidya","year":"2018"},{"key":"2024092007524332700_ocae160-B50","author":"Louisiana Board of Pharmacy","year":"2021"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/31\/10\/2337\/59206323\/ocae160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/31\/10\/2337\/59206323\/ocae160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:53:21Z","timestamp":1726818801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/31\/10\/2337\/7697035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,6,21]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocae160","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"value":"1067-5027","type":"print"},{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,21]]}}}